Scientific Company Directory

BMG LABTECH is a leading global manufacturer of innovative, high-quality, and reliable microplate reader instrumentation.

Biosearch Technologies is the comprehensive genomics portfolio from LGC, providing products and services for genomic analysis that support mission critical applications for global customers in agrigenomics and human healthcare.

The portfolio offers integrated tools and technologies to accelerate sample preparation, amplification, cloning and expression, next generation sequencing (NGS), custom oligonucleotide synthesis, nucleic acid chemistry reagents, and oligo therapeutics.

Whether through sbeadex™ DNA purification, oligos and reagents (KASP™, BHQplus™ Probes, BHQ™ Probe Master Mix), or proprietary sample prep and PCR instrumentation (oKtopure™, SNPline™, Nexar™ and IntelliQube™), we enable our customers from discovery to production-scale testing.

Biosearch Technologies is a leader in the agricultural genomics market and is increasingly adopted by researchers, with over 2,000 scientific papers citing KASP assays. Key applications include validation and screening of newly discovered SNPs in Marker-Assisted Selection and Marker-Assisted Breeding programmes for both plants and livestock.

Globally, our cGMP manufacturing and ISO 13485-compliant facilities support supply chain continuity, complementing our customers’ product development pipelines through our robust research grade and cGMP oligonucleotide manufacturing that achieves consistent scale up. For molecular diagnostics, Biosearch Technologies has proven expertise in NGS, isothermal, qPCR-based applications where our tools and technologies such as BHQ probes and proprietary PCR platforms are frequently used in LDTs, ASRs and in vitro diagnostics. Through our recently acquired Lucigen portfolio, we also offer custom and bulk enzymes and buffers as critical components for molecular diagnostics.

Sales offices are located in China, Germany, Singapore, UK, and US. Sales representatives are available throughout Europe, Latin America, and Asia Pacific, with distributors in other key territories. Visit www.biosearchtech.com.

Biolog, Inc. is a privately held company that began operations in Hayward California in 1984, where the company remains headquartered today. The company’s product lines have been built upon patented technology that greatly simplifies cell identification and characterization, with applicability across basic research, bioprocess, sustainable agriculture and other markets where microorganism characterization is key to success.

In 2022, Biolog received funding from private investors including BroadOak Capital and Research Corporation Technologies. That spurred additional growth, including the acquisition of MIDI Labs, now Biolog Lab Services,  a business that founded the DNA sequencing method for microbial identification and has, for over two decades, delivered critical, time-sensitive ID for pharmaceutical, probiotic, food and beverage, and personal care manufacturing customers.  

Today, Biolog produces instrumentation, test panels, and critical software for phenotype characterization in microbial organisms, mammalian cell lines, and community analysis. We also produce microbial identification panels to enable the identification of bacteria, yeast, and fungi using our instruments. At our Newark, DE site we provide complementary laboratory services where, in addition to our phenotypic characterization tools we offer a full polyphasic approach for microbial ID, including genotypic and proteotypic services.

Biolog sells direct in the US, Germany, and Austria and through distribution channels throughout the rest of the world.

BPS Bioscience’s purpose is to advance new scientific discoveries that lead to therapies by creating innovative solutions for research.

Breakthroughs in research rely on dependable model systems that accurately reflect biological systems. We are experts in protein design, expression, purification, and characterization, cell line and lentivirus engineering, and biochemical and cellular assay development. Our products and services have enabled thousands of researchers to advance biological discoveries across a wide variety of disciplines, including epigenetics, cell signaling, SARS-CoV-2, immunotherapy, adoptive cell therapies, and many more.

Science never stands still.  We focus on emerging research needs and rapidly deliver solutions.

Dassault Systèmes, the 3DEXPERIENCE Company, provides business and people with virtual universes to imagine sustainable innovations. By creating ‘virtual experience twins’ of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production. Dassault Systèmes helps Life Sciences companies shift the focus to deliver superior, patient-centric, outcome-driven experiences and creating the processes to support them transforms how therapies are discovered, developed, produced, commercialized and used. The group brings value to over 270, 000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com

Benchling is a cloud-based platform for biotechnology research and development. Benchling helps scientists accelerate the full R&D lifecycle with our R&D Cloud, which consists of data, collaboration, and insights built on a trusted and open platform.

bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.